Aurobindo Pharma Buyback 2026 Record Date Price Ratio Details
Check out Aurobindo Pharma Buyback 2026 Record Date Price Ratio Details, Kostak rates, and Subject to Sauda rates as of today. Aurobindo Pharma Buyback 2026 Record Date Price Ratio Details is started in grey market. Stay tuned for the latest IPO GMP numbers of Aurobindo Pharma Buyback 2026 Record Date Price Ratio Details.
Aurobindo Pharma Buyback 2026 Record Date Price Ratio Details made a high of ₹7 on 9th April, 2026, whereas the low of ₹1 on 16th April, 2026.
- GMP
- IPO Details
- Review
- Subscription
- Allotment
- Listing
- News
Aurobindo Pharma Buyback 2026 Record Date Price Ratio Details is to open on April 9, 2026. It is a Mainboard IPO that will raise ₹150 crores. The Aurobindo Pharma Buyback 2026 Record Date Price Ratio Details price band is fixed at ₹166 to ₹175 with a market lot of 85 Shares.
Aurobindo Pharma Buyback 2026 Record Date Price Ratio Details Live
| Date | IPO GMP | GMP Trend | Gain |
|---|---|---|---|
| 16 April | Rs 1 |  | 0.57% |
| 15 April | RS 4.5 |  | 2.57% |
| 14 April | RS 1.5 | | 0.86% |
| 13 April | RS 3 | | 1.71% |
| 11 April | RS 2 | | 1.21% |
| 10 April | RS 1.5 | | 0.86% |
| 9 April | RS 1.5 | | 0.86% |
| 16 April | - | - | - |
Aurobindo Pharma Buyback 2026 Record Date Price Ratio Details Details
| IPO Open Date | April 9, 2026 |
| IPO Close Date | April 13, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹166 to ₹175 Per Share |
| Issue Size | Approx ₹150 Crores |
| Fresh Issue | Approx ₹133 Crores |
| Offer for Sale: | Approx 10,00,000 Equity Shares |
| Issue Type | Book Building Issue |
| IPO Listing | BSE, NSE |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |
Aurobindo Pharma Buyback 2026 Record Date Price Ratio Details Dates
| IPO Open Date | April 9, 2026 |
| IPO Close Date | April 13, 2026 |
| Basis of Allotment: | April 15, 2026 |
| Refunds: | April 16, 2026 |
| Credit to Demat Account: | April 16, 2026 |
| IPO Listing Date: | April 17, 2026 |
| IPO Bidding Cut-off Time: | April 13, 2026 – 5 PM |
Business Overview
Aurobindo Pharma Buyback 2026 Record Date Price Ratio Details is a power transmission infrastructure engineering, procurement, and construction (EPC) company that has over 14 years of experience in the energy infrastructure sector. Founded in June 2011, the firm is involved in the execution of high-voltage (“HV”) and extra-high voltage (“EHV”) transmission lines, substations, and underground cabling projects.
From design, engineering, supply, erection, installation, testing, commissioning, to comprehensive operation and maintenance (“O&M”) services, the firm offers complete end-to-end services for a project.
Over the last 3 years, Aurobindo Pharma Buyback 2026 Record Date Price Ratio Details has completed more than 450 CKM (circuit kilometers) of transmission lines, underground cables, and built and operated 124 substations as well. As of December 31, 2025, the firm includes 1,164 permanent employees.
Aurobindo Pharma Buyback 2026 Record Date Price Ratio Details aka Grey Market Premium FAQs:
What is Aurobindo Pharma Buyback 2026 Record Date Price Ratio Details Today?
Aurobindo Pharma Buyback 2026 Record Date Price Ratio Details is ₹1 as of today.
What is Aurobindo Pharma Buyback 2026 Record Date Price Ratio Details Expected Returns?
Aurobindo Pharma Buyback 2026 Record Date Price Ratio Details Expected Returns is 0.57%.
Disclaimer:
Table of Contents
Meet VoraFounder of IPOWatch, brings nearly 15 years of experience in IPO analysis and market research. He provides complete coverage of upcoming IPOs, subscription trends, grey market premiums (GMP), and post-listing performance, along with easy-to-understand reviews, insights, and analysis. In his working journey, he has worked with various platforms and received expertise in stock market analysis and primary markets.
Add IPOWatch to your Google News feed.
Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.
Reply to
Your email address will not be published. Required fields are marked *
Testimonials
I had a fantastic experience using this website. The user interface is intuitive and easy to navigate, making it a breeze to find the information I needed. The content is well-organized and informative, providing valuable insights into the IPO market.
John Doe
Web Visitor
I had a fantastic experience using this website. The user interface is intuitive and easy to navigate, making it a breeze to find the information I needed. The content is well-organized and informative, providing valuable insights into the IPO market.
Jane Smith
Web Visitor
I had a fantastic experience using this website. The user interface is intuitive and easy to navigate, making it a breeze to find the information I needed. The content is well-organized and informative, providing valuable insights into the IPO market.
Bob Johnson
Web Visitor
I had a fantastic experience using this website. The user interface is intuitive and easy to navigate, making it a breeze to find the information I needed. The content is well-organized and informative, providing valuable insights into the IPO market.
Alice Williams
Web Visitor
I had a fantastic experience using this website. The user interface is intuitive and easy to navigate, making it a breeze to find the information I needed. The content is well-organized and informative, providing valuable insights into the IPO market.
Charlie Brown
Web Visitor
I had a fantastic experience using this website. The user interface is intuitive and easy to navigate, making it a breeze to find the information I needed. The content is well-organized and informative, providing valuable insights into the IPO market.
John Doe
Web Visitor
I had a fantastic experience using this website. The user interface is intuitive and easy to navigate, making it a breeze to find the information I needed. The content is well-organized and informative, providing valuable insights into the IPO market.
Jane Smith
Web Visitor
I had a fantastic experience using this website. The user interface is intuitive and easy to navigate, making it a breeze to find the information I needed. The content is well-organized and informative, providing valuable insights into the IPO market.
Bob Johnson
Web Visitor
I had a fantastic experience using this website. The user interface is intuitive and easy to navigate, making it a breeze to find the information I needed. The content is well-organized and informative, providing valuable insights into the IPO market.
Alice Williams
Web Visitor
I had a fantastic experience using this website. The user interface is intuitive and easy to navigate, making it a breeze to find the information I needed. The content is well-organized and informative, providing valuable insights into the IPO market.
Charlie Brown
Web Visitor